Thurston, Springer, Miller, Herd & Titak, Inc. Eli Lilly & CO Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $730 Million
- Q2 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 19,071 shares of LLY stock, worth $12.2 Million. This represents 2.04% of its overall portfolio holdings.
Number of Shares
19,071
Previous 17,209
10.82%
Holding current value
$12.2 Million
Previous $14.2 Million
4.59%
% of portfolio
2.04%
Previous 2.55%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
4,441Shares Held
781MCall Options Held
16.5MPut Options Held
12.2M-
Lilly Endowment Inc Indianapolis, IN96MShares$61.4 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA80.4MShares$51.4 Billion1.05% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$42.1 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$32.8 Billion26.07% of portfolio
-
State Street Corp Boston, MA34.5MShares$22.1 Billion1.04% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $608B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...